| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 07/04/2011 | 21h04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 07/04/2011 | 20h55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 07/04/2011 | 20h45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 07/04/2011 | 20h19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 07/04/2011 | 18h35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 07/04/2011 | 18h16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 05/04/2011 | 22h53 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 05/04/2011 | 22h52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 05/04/2011 | 22h39 | Business Wire | CPEX Completes Sale to FCB I Holdings | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 05/04/2011 | 21h59 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 05/04/2011 | 21h56 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 05/04/2011 | 20h46 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 05/04/2011 | 20h42 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 05/04/2011 | 19h53 | PR Newswire (US) | Footstar Completes Acquisition of CPEX Pharmaceuticals, Inc. | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 31/03/2011 | 16h54 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 30/03/2011 | 16h11 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 24/03/2011 | 14h21 | Business Wire | CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 23/03/2011 | 20h00 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 23/03/2011 | 12h00 | Business Wire | CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 23/03/2011 | 11h02 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 22/03/2011 | 13h30 | PR Newswire (US) | Mangrove Partners Notes CPEX Stock Trading Above Offer Price | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 21/03/2011 | 21h31 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 21/03/2011 | 16h56 | Business Wire | CPEX Advises Stockholders to Vote Today for the All-Cash, Premium FCB Transaction | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 21/03/2011 | 13h30 | PR Newswire (US) | Mangrove Partners Expresses Disappointment in Board of CPEX Pharmaceuticals, Inc. and Reaffirms Proposed Recapitalization and In | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 18/03/2011 | 21h27 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 18/03/2011 | 21h21 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 18/03/2011 | 14h36 | Business Wire | CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 17/03/2011 | 22h13 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 17/03/2011 | 22h09 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 17/03/2011 | 14h34 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |